BACKGROUND AND PURPOSE: MR contrast media are commonly used but do not have
evidence-based guidelines for their application. This investigation seeks to define specific …

At the dawn of the magnetic resonance era it was suggested that contrast media would not
be necessary because of the enhanced intrinsic tissue contrast already present with MRI. It …

The use of contrast agents combined with clinical MR imaging is still relatively new. While
gadolinium chelate contrast agents such as gadopentetate dimeglumine (Magnevist) share …

Gadopentetate dimeglumine is presently the only MR contrast agent approved by the FDA
for MR imaging of the brain and spine. The current recommended dose is 0. i mmol/kg, and …

Since their introduction, gadolinium-based contrast media are routinely used in most CNS
MR imaging indications. Due to their paramagnetic effect, they significantly shorten the T1 …

Intravenous contrast media are widely used in MR imaging of the brain. Clinical utility is high
in both neoplastic and non‐neoplastic disease. The agents approved to date are all …

Contrast enhancement has now become an interal part of MR imaging. In this paper, the
current uses of contrast agents in MR imaging of both the head and spine are reviewed. In …

ing an integral part of magnetic resonance imaging (MRI) examinations of the central
nervous system (CNS). The current applications of contrast media enhancement are diverse …

No single dose of MR contrast agent is optimal or adequate for the evaluation of all types of
brain tumors. An understanding of all the factors influencing lesion conspicuity is of …

The use of exogenous contrast media in magnetic resonance imaging of the brain has
brought dramatic improvement in the sensitivity of detection and delineation of pathological …